CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL

Clinical trial NCT05716113 · COMPLETED

Trial details

NCT number: NCT05716113
Sponsor: He Huang
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neoplasms Hematologic Neoplasms Neoplasms by Site Hematologic Diseases

Start date: 2023-02-09
Primary completion: 2024-08-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.